| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 10/28/2004 | WO2004058721A3 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 10/28/2004 | WO2004000826A8 Processes for producing epoxytriazole derivative and intermediate therefor |
| 10/28/2004 | US20040215024 naphthopyrans having an oxygen-containing heterocyclic group F annelated on the i, j, or k side of the naphthopyran ring; have interesting photochromic properties; part of polymer or in polymer matrix; ophthalmic lenses |
| 10/28/2004 | US20040215017 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
| 10/28/2004 | US20040214887 for example, 6,9-Dihydroxy-2,2,13,13-tetramethyl-tetradecanedioic acid, 2,2,13,13-Tetramethyl-tetradecane-1,6,9,14-tetraol, 6,10-Dihydroxy-2,2,14,14-tetramethyl-pentadecanedioic acid; treatment of Alzheimer's Disease, metabolic syndrome disorder, cancer, cardiovascular disease, diabetic nephropathy |
| 10/28/2004 | US20040214875 Imidazolinylmethyl aralkylsulfonamides |
| 10/28/2004 | US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles |
| 10/28/2004 | US20040214868 Treatment or prevention of type 2 diabetes; chemical synthesis; 2-[ benzoyl]aminopyridine-5-carboxylate derivatives |
| 10/28/2004 | US20040214857 Substituted benzimidazoles and imidazo-[4,5]-pyridines |
| 10/28/2004 | US20040214845 Barbiturates as integrin antagonists and their use for treating inflammatory diseases |
| 10/28/2004 | US20040214844 N4-acylcytosine nucleosides for treatment of viral infections |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214841 Quinazoline derivatives for treatment of tumours |
| 10/28/2004 | US20040214818 Alzheimer's disease; Parkinson's disease; Huntington's disease; cognition activators; learning enhancement; central nervous system disorders |
| 10/28/2004 | US20040214817 Diaminotriazoles useful as inhibitors of protein kinases |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug |
| 10/28/2004 | US20040213264 Service class and destination dominance traffic management |
| 10/28/2004 | CA2522595A1 Compositions useful as inhibitors of protein kinases |
| 10/28/2004 | CA2522522A1 Quinazoline compounds |
| 10/28/2004 | CA2522266A1 Phenylazole compound, production process therefor and antioxidant |
| 10/28/2004 | CA2522118A1 Compounds that modulate ppar activity and methods of preparation |
| 10/28/2004 | CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521915A1 Alpha substituted carboxylic acid as ppar modulators |
| 10/28/2004 | CA2520323A1 Tie-2 modulators and methods of use |
| 10/27/2004 | EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor |
| 10/27/2004 | EP1471064A1 Coumarin derivatives, process for their production and use thereof |
| 10/27/2004 | EP1471063A1 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 10/27/2004 | EP1471057A1 Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2 |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1470143A1 Compounds that inhibit factor xa activity |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 10/27/2004 | EP1470113A1 Pyrimidinone viral polymerase inhibitors |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1469851A1 Melanocortin receptor agonists |
| 10/27/2004 | EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 10/27/2004 | EP1073428B1 Dihydroxyphenyl derivatives for hepatoprotection and treatment of liver diseases |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1541259A Fluorescent diketopyrrolopyrrole analogues |
| 10/27/2004 | CN1541215A HIV inhibiting pyrimidines derivatives |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/27/2004 | CN1541203A 4-(phenyl-(piperidin-4-YL)-amino)-benzamide derivatives and their use for treatment of pain, anxiety or gastrointestinal disorders |
| 10/27/2004 | CN1539825A Compounds useful to treat retroviral infections |
| 10/27/2004 | CN1172930C PDE IV inhibiting pyridine derivatives |
| 10/27/2004 | CN1172917C Steroid receptor modulator compounds and methods |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 10/26/2004 | CA2295752C Novel process for manufacturing paroxetine solid dispersions |
| 10/26/2004 | CA2196263C Process for the preparation of 4-oxoimidazolinium salts |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004090543A1 Assay method |
| 10/21/2004 | WO2004089947A2 Novel compounds having an antibacterial activity |
| 10/21/2004 | WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 10/21/2004 | WO2004089939A1 Condensed furan derivatives as adenosine antagonists |
| 10/21/2004 | WO2004089932A1 Substituted pyrazole compounds |
| 10/21/2004 | WO2004089931A1 Substituted pyrazoles |
| 10/21/2004 | WO2004089927A1 Novel methods for the treatment of inflammatory diseases |
| 10/21/2004 | WO2004089925A1 Pi-3 kinase inhibitor prodrugs |
| 10/21/2004 | WO2004089914A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 10/21/2004 | WO2004089910A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders |
| 10/21/2004 | WO2004089908A2 3-azabicyclo[3.2.1]octane derivatives |
| 10/21/2004 | WO2004089903A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
| 10/21/2004 | WO2004089901A2 Phospholipase c inhibitors for use in treating inflammatory disorders |
| 10/21/2004 | WO2004089894A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 10/21/2004 | WO2004089892A2 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | WO2004089888A1 Pyrazole compounds |
| 10/21/2004 | WO2004089373A1 4- (4-(heterocyclylalkoxy}phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer’s |
| 10/21/2004 | WO2004089370A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
| 10/21/2004 | WO2004089367A1 Pharmaceutical use of substituted 1,2,4-triazoles |
| 10/21/2004 | WO2004089363A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 10/21/2004 | WO2004089362A1 2-cyanopyrroles and their analogues as ddp-iv inhibitors |
| 10/21/2004 | WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 10/21/2004 | WO2004058144A3 Antibacterial agents |
| 10/21/2004 | WO2004056786A3 Pyrimidine derivates for the treatment of abnormal cell growth |
| 10/21/2004 | WO2004047674A3 Oxyge-containing heterocyclic fused naphthopyrans |
| 10/21/2004 | US20040209981 Protective coating for food, beverages, drugs; cosmetics; shampoo; radiation resistance |
| 10/21/2004 | US20040209948 especially naphthalene sulfonamides, used for treating asthma |
| 10/21/2004 | US20040209940 potent antibacterial activity against various bacteria including drug-resistant strains |
| 10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/21/2004 | US20040209936 Compounds that modulate PPAR activity and methods of preparation |
| 10/21/2004 | US20040209929 Fused heteroaryl carboxylic acids as PPAR agonists |
| 10/21/2004 | US20040209925 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 10/21/2004 | US20040209922 Pyridine matrix metalloproteinase inhibitors |
| 10/21/2004 | US20040209915 substituted with an N- (p-hydroxy-alpha-hydroxybenzylaminoalkylpiperidinyloxy- (or -amino-)carbonylamino group; useful for identifying compounds having both beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209913 Bicyclic Heteroaromatic Alanines |
| 10/21/2004 | US20040209912 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 10/21/2004 | US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 10/21/2004 | US20040209904 Substituted quinazoline compounds useful as P38 kinase inhibitors |
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/21/2004 | US20040209884 Fused azabicycic compounds that inhibit vanilloid receptor subtype 1(VR1) receptor |
| 10/21/2004 | US20040209883 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |